Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Creative Medical Technology Holdings (CELZ) over the last 16 years, with Q3 2025 value amounting to -$1.2 million.

  • Creative Medical Technology Holdings' Net Cash Flow rose 350.35% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$884927.0, marking a year-over-year decrease of 15047.12%. This contributed to the annual value of $2.5 million for FY2024, which is 15096.23% up from last year.
  • Per Creative Medical Technology Holdings' latest filing, its Net Cash Flow stood at -$1.2 million for Q3 2025, which was up 350.35% from -$1.2 million recorded in Q2 2025.
  • Creative Medical Technology Holdings' 5-year Net Cash Flow high stood at $13.7 million for Q2 2022, and its period low was -$8.6 million during Q4 2022.
  • Moreover, its 5-year median value for Net Cash Flow was -$320036.0 (2024), whereas its average is $277763.1.
  • Over the last 5 years, Creative Medical Technology Holdings' Net Cash Flow had its largest YoY gain of 13153357.06% in 2021, and its largest YoY loss of 881706.2% in 2021.
  • Over the past 5 years, Creative Medical Technology Holdings' Net Cash Flow (Quarter) stood at $8.3 million in 2021, then crashed by 203.63% to -$8.6 million in 2022, then soared by 87.97% to -$1.0 million in 2023, then soared by 69.23% to -$320036.0 in 2024, then plummeted by 265.15% to -$1.2 million in 2025.
  • Its Net Cash Flow was -$1.2 million in Q3 2025, compared to -$1.2 million in Q2 2025 and $1.8 million in Q1 2025.